Valeo Financial Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Valeo Financial Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,473	Closed	-$9.89K	–	693
2023 Q1	$9.89K	Hold	27,473	–	–	﹤0.01%	610
2022 Q4	$24.3K	Buy	27,473 +1,000	+4%	+$1.33K	﹤0.01%	527
2022 Q3	$42K	Buy	26,473 +7,000	+36%	+$15.9K	﹤0.01%	483
2022 Q2	$39K	Hold	19,473	–	–	﹤0.01%	477
2022 Q1	$45K	Buy	19,473 +5,000	+35%	+$15.6K	﹤0.01%	604
2021 Q4	$67K	Buy	14,473 +100	+0.7%	+$621	﹤0.01%	559
2021 Q3	$110K	Buy	14,373 +1,373	+11%	+$11.6K	0.01%	530
2021 Q2	$126K	Hold	13,000	–	–	0.01%	460
2021 Q1	$108K	Buy	13,000 +3,000	+30%	+$31.7K	0.01%	592
2020 Q4	$68K	Hold	10,000	–	–	﹤0.01%	682
2020 Q3	$112K	Buy	10,000 +6,000	+150%	+$54.9K	0.01%	455
2020 Q2	$25K	Buy	+4,000	New	+$15.3K	﹤0.01%	986

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.21B AUM 21.86% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.15B AUM 34.45% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return